Close Menu

NEW YORK ─ The US Food and Drug Administration has issued an Emergency Use Authorization for Siemens Healthineers’ laboratory-based IL-6 assay to measure the presence of interleukin-6 in human serum or plasma, the firm said on Thursday.

Erlangen, Germany-based Siemens Healthineers said its blood test may be used to assist in identifying a severe inflammatory immune response in patients confirmed to have COVID-19, and to aid in determining the risk of needing intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.